Biotech

All Articles

Roivant unveils brand-new 'vant' to evolve Bayer high blood pressure med

.Matt Gline is actually back with a new 'vant' company, after the Roivant Sciences chief executive o...

Viridian eye illness period 3 favorites, accelerating push to rival Amgen

.Viridian Therapies' period 3 thyroid eye health condition (TED) scientific test has struck its own ...

Bain unveils $3B fund for life scientific research providers

.With a solid record for recognizing diamonds in the rough, Bain Resources Life Sciences (BCLS) has ...

Genentech's cancer cells restructure made 'for medical causes'

.The current choice to merge Genentech's two cancer cells teams was produced "scientific factors," e...

Tern dental GLP-1 reveals 5% fat loss at 1 month at best dose

.Terns Pharmaceuticals' decision to fall its liver condition passions may however settle, after the ...

Merck, Daiichi regular very early effectiveness in small mobile bronchi cancer along with updated ADC data

.Merck &amp Co.'s long-running initiative to land a strike on small mobile lung cancer (SCLC) has ac...

Boehringer, Bayer breakthrough lung cancer cells medications towards Astra battle

.Some individuals with non-small tissue bronchi cancer (NSCLC) have anomalies in a genetics called h...

MBX pursues $136M IPO to take opponent to Ascendis right into phase 3

.MBX has elaborated plans to take in over $136 thousand from its own IPO as the biotech wants to car...

Relay breast cancer cells records tee up clash with AstraZeneca's Truqap

.Relay Therapeutics has hammered its own survival target in a first-in-human boob cancer cells study...

AZ lays out AI-enabled TROP2 biomarker approach for Daiichi ADC

.AstraZeneca has used artificial intelligence to formulate an one-of-a-kind biomarker for its Daiich...